Cargando…

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial

BACKGROUND: This study evaluated the cost-effectiveness of replacing standard intravenous therapy (taxane) with oral S-1 therapy for first-line metastatic breast cancer treatment. METHODS: This cost-effectiveness analysis was based on data from a randomized phase III trial (SELECT BC). As cost-effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shiroiwa, Takeru, Fukuda, Takashi, Shimozuma, Kojiro, Mouri, Mitsuko, Hagiwara, Yasuhiro, Kawahara, Takuya, Ohsumi, Shozo, Hozumi, Yasuo, Sagara, Yoshiaki, Ohashi, Yasuo, Mukai, Hirofumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693567/ https://www.ncbi.nlm.nih.gov/pubmed/29149882 http://dx.doi.org/10.1186/s12885-017-3774-7

Ejemplares similares

Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study
por: Hagiwara, Yasuhiro, et al.
Publicado: (2017)

Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer
por: Hagiwara, Yasuhiro, et al.
Publicado: (2020)

Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial
por: Shiroiwa, T., et al.
Publicado: (2016)

Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L
por: Izumi, Shoki, et al.
Publicado: (2023)

Minimal important differences of EORTC QLQ-C30 for metastatic breast cancer patients: Results from a randomized clinical trial
por: Kawahara, Takuya, et al.
Publicado: (2022)

Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT Trial
por: Takumoto, Yuki, et al.
Publicado: (2022)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial
por: Shiroiwa, T, et al.
Publicado: (2011)

Psychometric properties of the Japanese version of the EQ-5D-Y by self-report and proxy-report: reliability and construct validity
por: Shiroiwa, T., et al.
Publicado: (2019)

Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study
por: Mukai, Hirofumi, et al.
Publicado: (2020)

Healthcare costs for the elderly in Japan: Analysis of medical care and long-term care claim records
por: Akiyama, Naomi, et al.
Publicado: (2018)

Valuation Survey of EQ-5D-Y Based on the International Common Protocol: Development of a Value Set in Japan
por: Shiroiwa, Takeru, et al.
Publicado: (2021)

Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur–uracil with CMF (N·SAS-BC 01 trial and CUBC trial)
por: Ohno, Shinji, et al.
Publicado: (2020)

EQ-5D-Y Population Norms for Japanese Children and Adolescents
por: Shiroiwa, Takeru, et al.
Publicado: (2021)

Probiotic Beverage with Soy Isoflavone Consumption for Breast Cancer Prevention: A Case-control Study
por: Toi, Masakazu, et al.
Publicado: (2013)

Development of a multiplicative, multi-attribute utility function and eight single-attribute utility functions for the Health Utilities Index Mark 3 in Japan
por: Noto, Shinichi, et al.
Publicado: (2020)

Rainbow of KIBOU (ROK) study: a Breast Cancer Survivor Cohort in Japan
por: Mizota, Yuri, et al.
Publicado: (2017)

Reported Incidents Involving Non-medical Care Workers and Nursery Teachers in Hospitals in Japan: An Analysis of the Japan Council for Quality Health Care Nationwide Database
por: Akiyama, Naomi, et al.
Publicado: (2022)

Critical Incident Reports Related to Ventilator Use: Analysis of the Japan Quality Council National Database
por: Akiyama, Naomi, et al.
Publicado: (2023)

Economic Evaluation of First-Line Pertuzumab Therapy in Patients with HER2-Positive Metastatic Breast Cancer in Japan
por: Moriwaki, Kensuke, et al.
Publicado: (2021)

WTP for a QALY and health states: More money for severer health states?
por: Shiroiwa, Takeru, et al.
Publicado: (2013)

Estimation of Lifetime QALYs Based on Lifestyle Behaviors
por: Noto, Shinichi, et al.
Publicado: (2021)

Pathological complete response of HER2-positive breast cancer to trastuzumab and chemotherapy can be predicted by HSD17B4 methylation
por: Fujii, Satoshi, et al.
Publicado: (2017)

Evaluation of the Interobserver Agreement in the Number of Mitotic Figures Breast Carcinoma as Simulation of Quality Monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS‐BC) Protocol
por: Tsuda, Hitoshi, et al.
Publicado: (2000)

Incident reports involving hospital administrative staff: analysis of data from the Japan Council for Quality Health care nationwide database
por: Akiyama, Naomi, et al.
Publicado: (2020)

Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors
por: Mukai, Hirofumi, et al.
Publicado: (2016)

Comparison of physicians’ and dentists’ incident reports in open data from the Japan Council for Quality Health Care: a mixed-method study
por: Akiyama, Naomi, et al.
Publicado: (2023)

Choking injuries: Associated factors and error-producing conditions among acute hospital patients in Japan
por: Akiyama, Naomi, et al.
Publicado: (2022)

Realities in cost-effectiveness analyses: a study of castration-resistant prostate cancer patients using a medical claims database
por: Kunisawa, Susumu, et al.
Publicado: (2015)

Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC)
por: Nakayama, Takahiro, et al.
Publicado: (2018)

Spatial Frequency Responses of Anisotropic Refractive Index Gratings Formed in Holographic Polymer Dispersed Liquid Crystals
por: Fukuda, Yoshiaki, et al.
Publicado: (2016)

A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients
por: Watanabe, Takanori, et al.
Publicado: (2019)

Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan
por: Takahashi, Masato, et al.
Publicado: (2021)

Improved incidence of end-stage renal disease of type 1 diabetes in Japan, from a hospital-based survey
por: Otani, Toshika, et al.
Publicado: (2016)

Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial
por: Tsuda, Hitoshi, et al.
Publicado: (2022)

Correction to: Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial
por: Tsuda, Hitoshi, et al.
Publicado: (2022)

Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry
por: Ohsumi, Shozo, et al.
Publicado: (2023)

Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
por: Inaguma, Daijo, et al.
Publicado: (2016)

A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy
por: Ohsumi, Shozo, et al.
Publicado: (2022)

Prospective observational study estimating willingness-to-pay for breast cancer treatments through contingent valuation method in Japanese breast cancer patients (JCOG1709A)
por: Iwatani, Tsuguo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cbr0ph430b2h0ll5gilol4g92b